Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TOP SEARCHES

Stocks popular

Crypto

Currencies

CFD

Support

enGene Highlights Bladder Cancer Therapy Data and 2027 Path

enGene used a company webinar to present preclinical findings on its investigational non-viral gene therapy, detalimogene voraplasmid, paired with a polidocanol surfactant bladder rinse. The discussion also highlighted the treatment burden facing patients with high-risk non-muscle invasive bladder cancer.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.